SetPoint Medical Corporation announced a financing transaction
As of August 8, 2013, the company announced that it has received $27,000,000 in its first tranche closing of the third round of funding from new investors Covidien Ventures, Boston Scientific Corporation, Action Potential Venture Capital Limited, a fund managed by GlaxoSmithKline plc, Investment Arm, and other existing investors Foundation Medical Partners, Morgenthaler, and Topspin Ventures.
On September 8, 2015, the company received $15,000,000 in its second tranche. The company has raised approximately $43,000,000 in funding so far in the transaction. As part of the round Juan-Pablo Mas of Action Potential Venture Capital joined the board of directors of the company.